Insulin pump maker Insulet has acquired Automated Glucose Management LLC’s belongings associated to its automated insulin supply know-how for $25 million.
The businesses have had a longtime partnership since 2016. The Calif.-based firm’s founders consulted with Insulet through the improvement of its Omnipod 5 Automated Insulin Supply system.
“AGC performed a vital position in facilitating the profitable translation of analysis into trade by collaborating carefully with Dr. Frank Doyle on the College of California Santa Barbara and with Insulet. It’s thrilling to see know-how come out of the analysis lab and mature right into a industrial utility that improves the lives of individuals with diabetes,” Eric Benjamin, government VP of innovation, technique and digital merchandise at Insulet, mentioned in an announcement.
That is the second acquisition of belongings introduced by Insulet this week. The Mass.-based firm additionally acquired belongings associated to Bigfoot Biomedical’s pump-based automated insulin supply (AID) applied sciences for $25 million.
At-home blood assortment gadget maker Tasso acquired CE Mark certification for its TassoOne Plus, a liquid blood assortment gadget for house diagnostic testing and decentralized scientific trials.
Receipt of the CE Mark permits the Seattle-based firm to increase its providing all through the European market.
Final summer season, Tasso acquired FDA 510(ok) clearance for its patch-like house blood assortment gadget, the Tasso+.
“The demand for handy, patient-centric care is exploding, and Tasso is on a mission to carry high-quality healthcare into properties worldwide,” Ben Casavant, CEO and cofounder of Tasso, mentioned in an announcement. “This CE Mark unlocks clinical-grade liquid blood assortment for decentralized scientific trials and residential healthcare throughout the European Union, accelerating and increasing entry to care. Regulatory clearances like this one are a testomony to the standard and security of our merchandise.”
Digital neurotherapeutic firm MindMaze introduced the launch of Izar, a wise peripheral for sufferers with impaired hand motor perform aimed toward bettering hand dexterity and power.
The hand-held gadget can detect faint ranges of a person’s finger and hand actions and has accompanying gaming content material for self-training to enhance pinch, dexterous grasp and grip.
Izar is obtainable within the U.S. and European nations, resembling France, Germany and Switzerland.
“It is extremely thrilling to have a tool for the hand that has the flexibility of Izar. It could possibly function a controller throughout reach-to-grasp actions, as a coach of grip pressure gradation, and as an assessor of dexterity,” Dr. John Krakauer, MindMaze’s chief medical director, mentioned in an announcement. “The gadget can also be extremely transportable, so it may be used throughout the continuum of care, which is vital because the higher limb, and the hand specifically, will get comparatively uncared for in neurorehabilitation.”
